Media Room

For Immediate Release

Truven Health Analytics Extends Free Access to Five Micromedex Mobile Apps for Apple Devices to Subscribers Globally

Drug Information, Drug Interactions, IV Compatibility, Pediatrics Essentials and NeoFax Essentials Now Available

Ann Arbor, MI, Aug. 28, 2013 — Truven Health Analytics™ today announced the release of the latest version of its Micromedex® Apple® iPhone® apps, giving current customers outside the US and Canada on-the-go access to the industry’s most trusted evidence-based clinical content for free.

The applications released to customers on Apple iTunes® this month include:

  • Micromedex Drug Information
  • Micromedex Drug Interactions
  • Micromedex IV Compatibility
  • Micromedex Pediatrics Essentials
  • Micromedex NeoFax® Essentials

Micromedex Drug Information is currently one of the most popular medical apps in Apple’s App Store, totalling over 1.5 million downloads since its original release. The app delivers actionable recommendations to take users beyond the drug package insert to find off-label indications, dosing recommendations, therapeutic class, administration, monitoring, toxicology, clinical teaching, and more, giving customers access to the highest quality evidence available. With this release, the Drug Information app is now available outside the US and Canada to current Micromedex subscribers at no charge. The app remains available for free to all users in the US and Canada.

With Micromedex Drug Interactions, customers can check up to 50 patient medications simultaneously for potentially harmful interactions. Severity ratings are assigned to each interaction, ranging from contraindicated to minor. Additionally, users can see why the drugs in question interact, how the results of those interactions will present in the patient, and recommendations for monitoring patient outcomes. This app is now available to Micromedex customers globally at no charge.

Users of the Micromedex IV Compatibility app can rely on the ultimate authority on IV compatibility information – Trissel’s™ 2 Clinical Pharmaceutics Database – to enhance patient safety when administering IV medications. This app provides access to drug-solution and drug-drug compatibility results, including contributing factors such as the physical compatibility, storage, study period, container, and chemical stability. This app is now available to Micromedex customers globally at no charge.

Micromedex Pediatrics Essentials empowers customers with comprehensive, pediatric-specific, evidence-based information required to treat this complex population. This mobile app provides reliable access to the details required to confidently make accurate and informed treatment decisions at the point of care. This app is now available globally at no charge to customers with a Micromedex subscription to Pediatric Drug Information.

Micromedex NeoFax Essentials incorporates evidence-based information beyond the FDA-approved indications. It provides access at the point of care to comprehensive, neonatal-specific, evidence-based information required to treat this complex population. This app is available globally at no charge to customers with a Micromedex subscription to NeoFax.

This release provides Micromedex subscribers outside the US and Canada with free access to five mobile apps currently available in the US and Canada. All were designed to provide healthcare professionals with the information they need, when and where they need it to make informed treatment decisions with confidence. Micromedex customers worldwide can access these applications for free with the use of an organizational customer password.

"As the use of mobile devices increase in clinical settings it becomes increasingly important for our evidence-based resources to be accessible that way, " said Thomas Hegelund, executive vice president at Truven Health Analytics. "By providing global access to these mobile apps, clinicians have easy mobile access to the trusted content and fast answers they need to make informed clinical decisions." All five of the Micromedex Apps are now available to customers outside the US and Canada for Apple iPhone®, iPad®, and iPod® touch.

For more information and to download each application, go to www.micromedex.com/mobile/global .

About Truven Health Analytics, part of the IBM Watson Health Business

Truven Health Analytics®, part of the IBM Watson Health™ business, provides market-leading performance improvement solutions built on data integrity, advanced analytics and domain expertise. For more than 40 years, our insights and solutions have been providing hospitals and clinicians, employers and health plans, state and federal government agencies, life sciences companies and policymakers, the facts they need to make confident decisions that directly affect the health and well-being of people and organizations in the US and around the world. The company was acquired by IBM in 2016 to help form a new business, Watson Health. Watson Health aspires to improve lives and give hope by delivering innovation to address the world’s most pressing health challenges through data and cognitive insights.

Truven Health Analytics owns some of the most trusted brands in healthcare, such as MarketScan®, 100 Top Hospitals®, Advantage Suite®, Micromedex®, Simpler® and ActionOI®. Truven Health has its principal offices in Ann Arbor, MI, Chicago, IL, and Denver, CO.


Brian Erni
For Truven Health Analytics
J. Roderick, Inc. Public Relations